Abstract

Objective: To compare the efficacy and toxicity of cyclosporin A (CsA) monotherapy with CsA plus methotrexate (MTX) combination therapy in patients with early rheumatoid arthritis (RA). Patients and methods: 120...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical efficacy of cyclosporin and natamycin for fungal keratitis.
Chengwen Yang ... Jingjing Cai
Pakistan journal of medical sciences | VOL. 40
Chengwen Yang, et. al.Chengwen Yang ... Jingjing Cai
18 Mar 2024
OP0179 Comparing Initial Treatment Strategies with Methotrexate on First Use of Biologic Therapy: Results from The Canadian Early Arthritis Cohort
S Gottheil ... E Keystone
Annals of the Rheumatic Diseases | VOL. 75
S Gottheil, et. al.S Gottheil ... E Keystone
01 Jun 2016
Effects of co-treatment with pioglitazone and methotrexate on experimentally induced rheumatoid arthritis in Wistar albino rats.
Tanushree Roy ... Santanu Kumar Tripathi
Indian Journal of Pharmacology | VOL. 49
Tanushree Roy, et. al.Tanushree Roy ... Santanu Kumar Tripathi
01 Jan 2017
THU0109 Treating to target ultrasound with clinical remission better effects than clinical remission in RRP
K Kume ... K Hatta
Annals of the Rheumatic Diseases | VOL. 71
K Kume, et. al.K Kume ... K Hatta
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
More than meets the eye
Elise Siegert ... Robert Biesen
Annals of the Rheumatic Diseases | VOL. -
Elise Siegert, et. al.Elise Siegert ... Robert Biesen
31 Aug 2024
Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness
Cecilia Leijding ... Daniel C Andersson
Annals of the Rheumatic Diseases | VOL. -
Cecilia Leijding, et. al.Cecilia Leijding ... Daniel C Andersson
28 Aug 2024
Correspondence on ‘Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis’ by Kim et al
Robert B M Landewé ... Maarten Boers
Annals of the Rheumatic Diseases | VOL. -
Robert B M Landewé, et. al.Robert B M Landewé ... Maarten Boers
28 Aug 2024
No sign of elevated cardiovascular risk in patients with seropositive rheumatoid arthritis who remain on stable antirheumatic therapy: results from the nationwide Norwegian Cardio-Rheuma Register
Eirik Ikdahl ... Anne M Kerola
Annals of the Rheumatic Diseases | VOL. 83
Eirik Ikdahl, et. al.Eirik Ikdahl ... Anne M Kerola
27 Aug 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.